Market Cap 1.09B
Revenue (ttm) 0.00
Net Income (ttm) -287.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.60
Volume 2,113,200
Avg Vol 4,172,386
Day's Range N/A - N/A
Shares Out 128.92M
Stochastic %K 50%
Beta 2.01
Analysts Strong Sell
Price Target $21.25

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
Beowulfdragonslayer
Beowulfdragonslayer Apr. 30 at 3:45 AM
$CMPS Insider ownership is low (~3.93%), and there have been 0 insiders buying in the last 3 years according to trackers
0 · Reply
Waldo_5150
Waldo_5150 Apr. 30 at 2:17 AM
$CMPS .... The government has been aware of the potential medical benefits of psilocybin for over 70 years ........... Government - Sanctioned Studies: During the 1960s, the U.S. government funded or authorized hundreds of studies. Notable examples include the Concord Prison Experiment (1961), which looked at reducing prisoner recidivism, and various studies on treating alcoholism and end-of-life anxiety. The Verdict: By the late 60s, clinical data suggested significant "positive effects" on mental health, but the drug's association with the anti-war movement and the "hippie" culture began to overshadow the science. .......
0 · Reply
Waldo_5150
Waldo_5150 Apr. 29 at 10:51 PM
$CMPS ... FDA approval will be a game changer for the treatment of Depression - float only 100 million - Stock was $40.00 .
0 · Reply
Millionaire11
Millionaire11 Apr. 29 at 10:50 PM
$CMPS tomorrow
0 · Reply
Millionaire11
Millionaire11 Apr. 29 at 10:48 PM
$CMPS this is going to consolidate above $8. This is a $5 billion dollar company being priced at $1 billion. Ridiculous!
0 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 10:35 PM
$CMPS says that’s all you guys get for penny pinching 🤏 gotta go big fist it’s gonna stretch past 10$ or no give’s shares
0 · Reply
Beowulfdragonslayer
Beowulfdragonslayer Apr. 29 at 10:35 PM
$CMPS 7.11 is the 20 day MA
1 · Reply
texmade2
texmade2 Apr. 29 at 9:08 PM
$CMPS can you bring it down to 7 gap fill I like to triple my shares.
1 · Reply
TheW17ARD
TheW17ARD Apr. 29 at 8:32 PM
$CMPS shorts better be careful how long they stay here. Short term bearish but when the approvals come… gonna get crazy in here
0 · Reply
Skidit100
Skidit100 Apr. 29 at 8:28 PM
$CMPS not much is going to happen with this stock until long term durability data in July
0 · Reply
Latest News on CMPS
COMPASS Pathways Transcript: Needham Virtual Psychedelics Forum

Apr 27, 2026, 11:00 AM EDT - 2 days ago

COMPASS Pathways Transcript: Needham Virtual Psychedelics Forum


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 9 days ago

Psychedelic stocks rally with Trump's support

ATAI DFTX GHRS


COMPASS Pathways Transcript: Stifel 2026 Virtual CNS Forum

Mar 18, 2026, 10:30 AM EDT - 6 weeks ago

COMPASS Pathways Transcript: Stifel 2026 Virtual CNS Forum


COMPASS Pathways Transcript: Study update

Feb 17, 2026, 8:00 AM EST - 2 months ago

COMPASS Pathways Transcript: Study update


COMPASS Pathways Transcript: KOL Event

Jan 7, 2026, 10:00 AM EST - 4 months ago

COMPASS Pathways Transcript: KOL Event


COMPASS Pathways Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 10:40 AM EST - 6 months ago

COMPASS Pathways Transcript: Stifel 2025 Healthcare Conference


COMPASS Pathways Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 6 months ago

COMPASS Pathways Earnings Call Transcript: Q3 2025


COMPASS Pathways Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:00 AM EDT - 9 months ago

COMPASS Pathways Earnings Call Transcript: Q2 2025


Compass Pathways Appoints Justin Gover to Board of Directors

Jul 29, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways Appoints Justin Gover to Board of Directors


Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 11 months ago

Compass Pathways' depression drug succeeds late-stage trial


COMPASS Pathways Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

COMPASS Pathways Earnings Call Transcript: Q1 2025


This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 1 year ago

This Is a Test From GlobeNewswire

ALVO


COMPASS Pathways Transcript: Stifel’s 2025 Virtual CNS Forum

Mar 18, 2025, 11:30 AM EDT - 1 year ago

COMPASS Pathways Transcript: Stifel’s 2025 Virtual CNS Forum


COMPASS Pathways Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

COMPASS Pathways Earnings Call Transcript: Q4 2024


COMPASS Pathways Earnings Call Transcript: Q3 2024

Oct 31, 2024, 8:00 AM EDT - 1 year ago

COMPASS Pathways Earnings Call Transcript: Q3 2024


COMPASS Pathways Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:00 AM EDT - 1 year ago

COMPASS Pathways Earnings Call Transcript: Q2 2024


COMPASS Pathways Earnings Call Transcript: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

COMPASS Pathways Earnings Call Transcript: Q1 2024


COMPASS Pathways Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:00 AM EST - 2 years ago

COMPASS Pathways Earnings Call Transcript: Q4 2023


COMPASS Pathways Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

COMPASS Pathways Earnings Call Transcript: Q3 2023


COMPASS Pathways Earnings Call Transcript: Q2 2023

Aug 3, 2023, 8:00 AM EDT - 2 years ago

COMPASS Pathways Earnings Call Transcript: Q2 2023


COMPASS Pathways Transcript: Status Update

Jul 11, 2023, 8:00 AM EDT - 3 years ago

COMPASS Pathways Transcript: Status Update


COMPASS Pathways Earnings Call Transcript: Q1 2023

May 11, 2023, 9:30 AM EDT - 3 years ago

COMPASS Pathways Earnings Call Transcript: Q1 2023


COMPASS Pathways Earnings Call Transcript: Q4 2022

Feb 28, 2023, 8:00 AM EST - 3 years ago

COMPASS Pathways Earnings Call Transcript: Q4 2022


COMPASS Pathways Earnings Call Transcript: Q3 2022

Nov 3, 2022, 4:00 AM EDT - 3 years ago

COMPASS Pathways Earnings Call Transcript: Q3 2022


COMPASS Pathways Earnings Call Transcript: Q2 2022

Aug 3, 2022, 10:11 PM EDT - 4 years ago

COMPASS Pathways Earnings Call Transcript: Q2 2022


COMPASS Pathways Transcript: AGM 2022

Jun 16, 2022, 12:00 AM EDT - 4 years ago

COMPASS Pathways Transcript: AGM 2022


COMPASS Pathways Earnings Call Transcript: Q1 2022

May 10, 2022, 7:55 AM EDT - 4 years ago

COMPASS Pathways Earnings Call Transcript: Q1 2022


COMPASS Pathways Earnings Call Transcript: Q4 2021

Feb 24, 2022, 1:30 AM EST - 4 years ago

COMPASS Pathways Earnings Call Transcript: Q4 2021


COMPASS Pathways Earnings Call Transcript: Q3 2021

Nov 9, 2021, 1:38 AM EST - 4 years ago

COMPASS Pathways Earnings Call Transcript: Q3 2021


COMPASS Pathways Earnings Call Transcript: Q2 2021

Aug 11, 2021, 8:00 AM EDT - 5 years ago

COMPASS Pathways Earnings Call Transcript: Q2 2021


COMPASS Pathways Earnings Call Transcript: Q1 2021

May 13, 2021, 8:00 AM EDT - 5 years ago

COMPASS Pathways Earnings Call Transcript: Q1 2021


COMPASS Pathways Earnings Call Transcript: Q4 2020

Mar 9, 2021, 8:00 AM EST - 5 years ago

COMPASS Pathways Earnings Call Transcript: Q4 2020


COMPASS Pathways Earnings Call Transcript: Q3 2020

Nov 12, 2020, 8:00 AM EST - 5 years ago

COMPASS Pathways Earnings Call Transcript: Q3 2020


Beowulfdragonslayer
Beowulfdragonslayer Apr. 30 at 3:45 AM
$CMPS Insider ownership is low (~3.93%), and there have been 0 insiders buying in the last 3 years according to trackers
0 · Reply
Waldo_5150
Waldo_5150 Apr. 30 at 2:17 AM
$CMPS .... The government has been aware of the potential medical benefits of psilocybin for over 70 years ........... Government - Sanctioned Studies: During the 1960s, the U.S. government funded or authorized hundreds of studies. Notable examples include the Concord Prison Experiment (1961), which looked at reducing prisoner recidivism, and various studies on treating alcoholism and end-of-life anxiety. The Verdict: By the late 60s, clinical data suggested significant "positive effects" on mental health, but the drug's association with the anti-war movement and the "hippie" culture began to overshadow the science. .......
0 · Reply
Waldo_5150
Waldo_5150 Apr. 29 at 10:51 PM
$CMPS ... FDA approval will be a game changer for the treatment of Depression - float only 100 million - Stock was $40.00 .
0 · Reply
Millionaire11
Millionaire11 Apr. 29 at 10:50 PM
$CMPS tomorrow
0 · Reply
Millionaire11
Millionaire11 Apr. 29 at 10:48 PM
$CMPS this is going to consolidate above $8. This is a $5 billion dollar company being priced at $1 billion. Ridiculous!
0 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 10:35 PM
$CMPS says that’s all you guys get for penny pinching 🤏 gotta go big fist it’s gonna stretch past 10$ or no give’s shares
0 · Reply
Beowulfdragonslayer
Beowulfdragonslayer Apr. 29 at 10:35 PM
$CMPS 7.11 is the 20 day MA
1 · Reply
texmade2
texmade2 Apr. 29 at 9:08 PM
$CMPS can you bring it down to 7 gap fill I like to triple my shares.
1 · Reply
TheW17ARD
TheW17ARD Apr. 29 at 8:32 PM
$CMPS shorts better be careful how long they stay here. Short term bearish but when the approvals come… gonna get crazy in here
0 · Reply
Skidit100
Skidit100 Apr. 29 at 8:28 PM
$CMPS not much is going to happen with this stock until long term durability data in July
0 · Reply
Framingtheworld
Framingtheworld Apr. 29 at 8:04 PM
$ATAI $CMPS the “ANALyst” price targets are outlandish considering this price action that has turned a bit bearish after profit taking on the latest rally
1 · Reply
FBP
FBP Apr. 29 at 6:29 PM
$CMPS sold higher happy to reload in 6-7s
1 · Reply
Lowkeyoptions
Lowkeyoptions Apr. 29 at 4:28 PM
$AKAN low floater on watch $ATAI $CMPS $TLRY ON WATCH Akanda is an international medical cannabis & hemp and wellness platform company seeking to help people lead better lives through improved access to high-quality and affordable products.
0 · Reply
HamBoneXoXo
HamBoneXoXo Apr. 29 at 4:00 PM
$CMPS $CMPS Friend of my wife’s cousin just texted seeing seven J&J VPs pulling into Macdonald near Compass headquarters. Something must be up.
1 · Reply
Millionaire11
Millionaire11 Apr. 29 at 2:53 PM
$CMPS everything is going according to plan. Thank you God. I trust you
1 · Reply
WolfofTheCaribbean
WolfofTheCaribbean Apr. 29 at 1:46 PM
$CMPS Who are the likely "Predators"? 1. Johnson & Johnson (JNJ): They already have the clinical infrastructure for Spravato; COMP360 would be the natural "premium" upgrade to their portfolio. 2. AbbVie (ABBV): Known for aggressive acquisitions to fill their pipeline as older blockbusters lose patent protection. 3. Biogen (BIIB): Following their rollercoaster with Alzheimer's drugs, they are hungry for high-impact CNS (Central Nervous System) breakthroughs.
1 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 12:59 PM
0 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 12:51 PM
$CMPS anylyst maintain 70$ price target
0 · Reply
SanKish
SanKish Apr. 29 at 12:29 PM
$CMPS I am selling CSPs for now. Need some side earning. If I can pick some more between 7.5 - 8, I am ok.
1 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 11:40 AM
$CMPS when’s Timothy Sykes going to pump this
0 · Reply
JIMMYRIZZ
JIMMYRIZZ Apr. 29 at 2:09 AM
$CMPS 13.58$
1 · Reply
texmade2
texmade2 Apr. 29 at 1:36 AM
$CMPS 8.44, just above support, 7.84
0 · Reply